In our recent study, we have demonstrated that ceritinib, an anaplastic lymphoma kinase (ALK)-positive inhibitor for lung cancer treatment [23,24], is able induce breast cancer stem cell sphere explosion and death [10]. The gene discussed is ALK; the disease is lung cancer.